Ruth Plager, President, brings more than 25 years of experience, including a decade of consulting to dynamic biopharmaceutical companies. Clients include emerging companies on both coasts. Her track record includes successes with first in class products, late entries, mature products and drug delivery extensions--from a Business Development, New Product Planning, and Line Product Marketing Perspective. The foundation for her consulting practice is built on experience gained at Pfizer, Syntex International and Enzon. Her broad commercial experience calibrating the competitive landscape across all leading therapy areas insures that “the right questions” are asked and answered for our clients. Ruth’s network is further enhanced by her involvement in the LES HealthCare Committee and the developoment of HealthCare Workshops for Annual LES Meetings. Ruth received her B.S. Degree from the University of Wisconsin. She spent a year in Cancer Research at the Weizmann Institute of Science, in Israel, and in addition, attended a series of Health Economics courses at Stanford's Graduate School of Business
	Ruth received her B.S. Degree from the University of Wisconsin. She spent a year in Cancer Research at the Weizmann Institute of Science, in Israel, and in addition, attended a series of Health Economics courses at Stanford's Graduate School of Business.
ZenithBIO's successes highlight flexibility and breadth of industry expertise.  Examples include identifying in-licensing clinical stage opportunities and novel research opportunities. In addition, we conduct exceptional primary market research with key customer segments to insure optimal development of pre-clinical and clinical opportunities.